Literature DB >> 24577490

[Recipes systemic lupus erythematosus].

M Aringer1, M Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24577490     DOI： 10.1007/s00393-013-1324-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  12 in total

Review 1.  Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Authors:  M Aringer; H Burkhardt; G R Burmester; R Fischer-Betz; M Fleck; W Graninger; F Hiepe; A M Jacobi; I Kötter; H J Lakomek; H M Lorenz; B Manger; G Schett; R E Schmidt; M Schneider; H Schulze-Koops; J S Smolen; C Specker; T Stoll; A Strangfeld; H P Tony; P M Villiger; R Voll; T Witte; T Dörner
Journal:  Lupus       Date:  2011-11-09       Impact factor: 2.911

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  [Systemic lupus erythematosus--activity and outcome].

Authors:  M Aringer; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 4.  [Systemic lupus erythematosus].

Authors:  M Aringer; F Hiepe
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

5.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Authors:  Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-08

6.  Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.

Authors:  Rebecca Fischer-Betz; Gamal Chehab; Oliver Sander; Stefan Vordenbäumen; Adina Voiculescu; Ralph Brinks; Matthias Schneider
Journal:  J Rheumatol       Date:  2012-09-15       Impact factor: 4.666

7.  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Authors:  M Mosca; C Tani; M Aringer; S Bombardieri; D Boumpas; R Brey; R Cervera; A Doria; D Jayne; M A Khamashta; A Kuhn; C Gordon; M Petri; O P Rekvig; M Schneider; Y Sherer; Y Shoenfeld; J S Smolen; R Talarico; A Tincani; R F van Vollenhoven; M M Ward; V P Werth; L Carmona
Journal:  Ann Rheum Dis       Date:  2009-11-05       Impact factor: 19.103

Review 8.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Authors:  F A Houssiau; C Vasconcelos; D D'Cruz; G D Sebastiani; E de Ramon Garrido; M G Danieli; D Abramovicz; D Blockmans; A Cauli; H Direskeneli; M Galeazzi; A Gül; Y Levy; P Petera; R Popovic; R Petrovic; R A Sinico; R Cattaneo; J Font; G Depresseux; J-P Cosyns; R Cervera
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103
View more
  4 in total

Review 1.  [State of the art: systemic lupus erythematosus].

Authors:  J Mucke; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

2.  [Shared decision making even for complex systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE)?]

Authors:  M Schneider; H Carnarius; T Schlegl
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

Review 3.  [Management of systemic lupus erythematosus].

Authors:  M Aringer; M Schneider
Journal:  Internist (Berl)       Date:  2016-11       Impact factor: 0.743

4.  [21/f-Arthralgia and skin lesions : Preparation for the medical specialist examination: part 79].

Authors:  J Mucke
Journal:  Internist (Berl)       Date:  2021-07-15       Impact factor: 0.743
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.